Cargando…
Demethoxycurcumin analogue DMC-BH inhibits orthotopic growth of glioma stem cells by targeting JNK/ERK signaling
Glioma stem cells (GSCs) play an important role in glioblastoma resistance to conventional therapies and disease recurrence. Here, we assessed the therapeutic effect of a demethoxycurcumin analogue, DMC-BH, on GSCs, and investigated the underlying mechanisms. Our in vitro data demonstrate that DMC-B...
Autores principales: | Shi, Lei, Sun, Guan, Zhu, Haifeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425509/ https://www.ncbi.nlm.nih.gov/pubmed/32710727 http://dx.doi.org/10.18632/aging.103531 |
Ejemplares similares
-
Demethoxycurcumin analogue DMC-BH exhibits potent anticancer effects on orthotopic glioblastomas
por: Shi, Lei, et al.
Publicado: (2020) -
Demethoxycurcumin represses cervical cancer growth through PPARγ-regulated proliferation and apoptosis: DMC suppresses cervical cancer tumorigenesis
por: Tang, Jing, et al.
Publicado: (2023) -
ABCG2 downregulation in glioma stem cells enhances the therapeutic efficacy of demethoxycurcumin
por: Chen, Long, et al.
Publicado: (2017) -
Promising antitumor effects of the curcumin analog DMC-BH on colorectal cancer cells
por: Liu, Gang, et al.
Publicado: (2023) -
Demethoxycurcumin Retards Cell Growth and Induces Apoptosis in Human Brain Malignant Glioma GBM 8401 Cells
por: Huang, Tzuu-Yuan, et al.
Publicado: (2012)